TriSalus Life Sciences, Inc.TriSalus Life Sciences, Inc.TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.

No trades
See on Supercharts

TLSI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
TLSI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company